Day 1 | Day 2 | Download Brochure
TUESDAY, JUNE 5
7:15 am Registration & Morning Coffee
Program Scientific Advisor: Corinne Augelli-Szafran, Ph.D., Director, Laboratory for Experimental Alzheimer Drugs (LEAD), Harvard Medical School, Department of Neurology Center for Neurologic Diseases Brigham and Women’s Hospital
8:00 Chairperson’s Opening Remarks
Marcelle Bergeron, Ph.D., Director, Neuropharmacology, Elan Pharmaceuticals
8:10 Talk Title to be Announced
Marcelle Bergeron, Ph.D., Director, Neuropharmacology, Elan Pharmaceuticals
8:40 Hunting for IgG Biomarkers for Alzheimer’s
Dwight German, Ph.D., Professor, Department of Psychiatry, University of Texas Southwestern Medical Center
9:10 Sponsored Presentations (Opportunities Available)
9:40 Surgery and Anesthesia as Modifiers of Alzheimer’s Trajectory
Roderic G. Eckenhoff, M.D., Vice Chair for Research, Austin Lamont Professor of Anesthesiology & Critical Care, Perelman School of Medicine, University of Pennsylvania
10:10 Coffee Break
10:40 Sponsored Presentations (Opportunities Available)
Novel Approaches To Drug Discovery Through Alternative Targets
11:10 Novel NMDA Receptor Antagonists for Treatment of AD
Adeboye Adejare, Ph.D., Professor, Pharmaceutical Sciences, University of the Sciences, Philadelphia College of Pharmacy
11:40 PP2A – A Novel Target for Alzheimer’s Disease Therapeutics
Steven Braithwaite, Ph.D., Senior Vice President, Drug Discovery, Neuroscience, Signum Biosciences
12:10 pm Luncheon Presentation
Sponsored by
Development of Analytically Validated CSF Biomarker Assays for Alzheimer’s Disease
Pankaj Oberoi, Ph.D., Director, Scientific Services and Research & Development, Meso Scale Discovery
1:10 Session Break
1:30 Chairperson’s Remarks
Corinne Augelli-Szafran, Ph.D., Director, Laboratory for Experimental Alzheimer Drugs (LEAD), Harvard Medical School, Department of Neurology Center for Neurologic Diseases Brigham and Women’s Hospital
1:40 Enhancing Antibody Uptake in Brain to Target BACE1
Jasvinder K. Atwal, Ph.D., Senior Research Associate, Neuroscience, Genentech
2:10 EXPERT PANEL: The Mild Cognitive Impairment Test
Moderator: Corinne Augelli-Szafran, Ph.D., Director, Laboratory for Experimental Alzheimer Drugs (LEAD), Harvard Medical School, Department of Neurology; Center for Neurologic Diseases Brigham and Women’s Hospital
» 2:40 KEYNOTE PRESENTATION
Converting Knowledge of Ab Biology into Disease-Modifying Therapeutics
Dennis J. Selkoe, M.D., Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School; Co-Director, Center for Neurologic Diseases, Brigham and Women’s Hospital
|
3:40 Refreshment Break in the Exhibit Hall with Poster Viewing
4:40 Interactive Discussion Groups
Concurrent problem-solving discussions on specific topics, to provide a forum for exchanging ideas, voicing opinions and meeting potential collaborators. Discussions will be led by a moderator/s, limited to 15 participants per table, and open to all attendees and exhibitors.
5:40 Welcome Reception in the Exhibit Hall with Poster Viewing
6:45 End of Day
Day 1 | Day 2 | Download Brochure